Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Zamko Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer established in 2014 with a manufacturing facility at Sundar Industrial Estate.

Zamko Pharmaceuticals products in Pakistan

Zamko Pharmaceuticals (Pvt) Ltd has 18 medicine presentations registered in Pakistan under 10 brands, covering 9 generic medicines. Most of its products are in Anti-infectives and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Clicin (Clarithromycin), Kozivin (Azithromycin), Oxalive (Levofloxacin) and PD Zole (Omeprazole). 18 products have an official DRAP price on MedInfoBase. See all 10 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation14 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date1 Jul 2025Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 21 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Legal / official name
Zamko Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
641-A, Sundar Industrial Estate, Raiwind Road, Lahore, Pakistan
Corporate source details checked
21 Oct 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000890 Zamko Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000890 18 linked products · source seen 14 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx31public portfolio records represented
REG28unique registrations represented
IDX18indexed MedInfoBase presentations
SRC11additional source-observed presentations
R+2registry-only registrations
VER9registry-verified exact registrations
PKR18current validated price records
G9generic molecules in indexed catalogue
DF3dosage-form groups
TA2therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage58%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage94%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixZamko Pharmaceuticals (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zamko-pharmaceuticals-pvt-ltdGenerated 14 Nov 2026Anti-infectives16 · 89%Gastrointestinal & hepatology2 · 11%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioZamko Pharmaceuticals (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zamko-pharmaceuticals-pvt-ltdGenerated 14 Nov 202618presentationsTablet9 · 50%Capsule5 · 28%Suspension4 · 22%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionZamko Pharmaceuticals (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zamko-pharmaceuticals-pvt-ltdGenerated 14 Nov 202617comparable productsBelow peer median2 · 12%Near peer median10 · 59%Above peer median5 · 29%Company median price position+1.4%Lowest-price equivalents0Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsZamko Pharmaceuticals (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zamko-pharmaceuticals-pvt-ltdGenerated 14 Nov 2026Nabiqasim Industries (Pvt) Ltd.,9 shared100% overlapM/s. Genix Pharma (Pvt) Ltd.9 shared100% overlapPharmasol (Pvt) Ltd.9 shared100% overlapCCL Pharmaceuticals (Pvt.) Limited9 shared100% overlapValor Pharmaceuticals9 shared100% overlapHIGH-Q Pharmaceuticals9 shared100% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Formulation footprint

Dosage forms

Tablet9 products
Capsule5 products
Suspension4 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Zamko Pharmaceuticals (Pvt) Ltd. is priced against the market

17 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers18Distinct registrations among indexed, published, presentation-validated products only
Verified price observations18
Products with a verified price18
Products with multiple price observations0
Source records with multiple versions18
Latest portfolio source check9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation14 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

28 unique registration(s) · 18 indexed presentation(s) · 11 additional source-observed presentation(s) · 2 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Clicin Clarithromycin 500 mg Tablet 10's 096554 PKR 787.23 PKR 78.72/tablet 🔒 Pharma Pro
Clicin Clarithromycin 250 mg Tablet 10's 096558 PKR 472.34 PKR 47.23/tablet 🔒 Pharma Pro
Clicin Clarithromycin 125 mg/5 mL Suspension 60ml 096567 PKR 438.88 PKR 7.31/mL 🔒 Pharma Pro
Clicin Clarithromycin 250 mg/5 mL Suspension 60ml 096568 PKR 699.49 PKR 11.66/mL 🔒 Pharma Pro
Estomag 20mg CapsulesRegistry verified Esomeprazole (as magnesium trihydrate enteric coated pellets) — — — 096569Official source ↗ No indexed price — —
Estomag 40mg CapsulesRegistry verified Esomeprazole (as magnesium trihydrate) — — — 096570Official source ↗ No indexed price — —
Itrazam Itraconazole 100 mg Capsule 4's 096578 PKR 590.42 PKR 147.61/capsule 🔒 Pharma Pro
Kozivin Azithromycin 200 mg/5 mL Suspension 15ml 096565 PKR 324.73 PKR 21.65/mL 🔒 Pharma Pro
Kozivin Azithromycin 250 mg Capsule 6's 096579 PKR 290.82 PKR 48.47/capsule 🔒 Pharma Pro
Kozivin Azithromycin 500 mg Tablet 6's 104647 PKR 541.22 PKR 90.20/tablet 🔒 Pharma Pro
Oxalive Levofloxacin 500 mg Tablet 10's 096560 PKR 818.72 PKR 81.87/tablet 🔒 Pharma Pro
Oxalive Levofloxacin 250 mg Tablet 10's 096562 PKR 492.02 PKR 49.20/tablet 🔒 Pharma Pro
Oxizam Moxifloxacin 400 mg Tablet 5's 096555 PKR 934.84 PKR 186.97/tablet 🔒 Pharma Pro
PD Con Fluconazole 150 mg Capsule 1's 106309 PKR 128.70 PKR 128.70/capsule 🔒 Pharma Pro
PD Zole Omeprazole 20 mg Capsule 2x7's 096571 PKR 944.50 PKR 67.46/capsule 🔒 Pharma Pro
PD Zole Omeprazole 40 mg Capsule 2x7's 096572 PKR 492.02 PKR 35.14/capsule 🔒 Pharma Pro
Quinalox Ciprofloxacin 250 mg Tablet 10's 096553 PKR 350.67 PKR 35.07/tablet 🔒 Pharma Pro
Quinalox Ciprofloxacin 500 mg Tablet 10's 097423 PKR 617.19 PKR 61.72/tablet 🔒 Pharma Pro
VorizemSource observed Voriconazole 50 mg Tablet 1x10’s 135450Official source ↗ No indexed price — —
VorizemSource observed Voriconazole 200 mg Tablet 1x10’s 135451Official source ↗ No indexed price — —
Zamlide Linezolid 600 mg Tablet 2x6's 096552 PKR 5,030.41 PKR 419.20/tablet 🔒 Pharma Pro
Zamlide Dry Powdered Linezolid 200 mg/5 mL Suspension 60ml 096564 PKR 688.83 PKR 11.48/mL No comparator
Zefentrine 20Source observed Artemether + Lumefantrine 20 mg + 120 mg Tablet 16’s 135444Official source ↗ No indexed price — —
Zefentrine DS 40Source observed Artemether + Lumefantrine 40 mg + 240 mg Tablet 10’s 135445Official source ↗ No indexed price — —
Zefentrine ES 80Source observed Artemether + Lumefantrine 80 mg + 480 mg Tablet 8’s 135446Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 250 mg Tablet 3x10’s 135447Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 250 mg Tablet 1x10’s 135447Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 500 mg Tablet 3x10’s 135448Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 500 mg Tablet 1x10’s 135448Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 750 mg Tablet 1x10’s 135449Official source ↗ No indexed price — —
ZemcetumSource observed Levetiracetam 750 mg Tablet 3x10’s 135449Official source ↗ No indexed price — —
A to Z

All 10 Zamko Pharmaceuticals brands in Pakistan

  • Clicin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Itrazam Itraconazole · 100 mg capsule
  • Kozivin Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
  • Oxalive Levofloxacin · 250 mg tablet, 500 mg tablet
  • Oxizam Moxifloxacin · 400 mg tablet
  • PD Con Fluconazole · 150 mg capsule
  • PD Zole Omeprazole · 20 mg capsule, 40 mg capsule
  • Quinalox Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Zamlide Linezolid · 600 mg tablet
  • Zamlide Dry Powdered Linezolid · 200 mg/5 mL suspension
Questions

Zamko Pharmaceuticals: common questions

How many products does Zamko Pharmaceuticals have in Pakistan?

Zamko Pharmaceuticals (Pvt) Ltd has 18 registered medicine presentations in Pakistan, sold under 10 brands and covering 9 generic medicines.

What are the main brands of Zamko Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Clicin (Clarithromycin), Kozivin (Azithromycin), Oxalive (Levofloxacin), PD Zole (Omeprazole) and Quinalox (Ciprofloxacin). This is not a sales ranking.

Which therapy areas does Zamko Pharmaceuticals cover?

The most products are in Anti-infectives (16) and Gastrointestinal & hepatology (2).

Where can I see Zamko Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Zamko Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 14, 2026, from https://medinfobase.com/company/zamko-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9